Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
In general, proteins can only execute their various biological functions when they are appropriately folded. Their amino acid sequence encodes the relevant information required for correct three-dimensional folding, with or without the assistance of chaperones. The challenge associated with understanding protein folding is currently one of the most important aspects of the biological sciences. Misfolded protein intermediates form large polymers of unwanted aggregates and are involved in the pathogenesis of many human diseases, including Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM). AD is one of the most prevalent neurological disorders and has worldwide impact; whereas T2DM is considered a metabolic disease that detrementally influences numerous organs, afflicts some 8% of the adult population, and shares many risk factors with AD. Research data indicates that there is a widespread conformational change in the proteins involved in AD and T2DM that form β-sheet like motifs. Although conformation of these β-sheets is common to many functional proteins, the transition from α-helix to β-sheet is a typical characteristic of amyloid deposits. Any abnormality in this transition results in protein aggregation and generation of insoluble fibrils. The abnormal and toxic proteins can interact with other native proteins and consequently catalyze their transition into the toxic state. Both AD and T2DM are prevalent in the aged population. AD is characterized by the accumulation of amyloid-β (Aβ) in brain, while T2DM is characterized by the deposition of islet amyloid polypeptide (IAPP, also known as amylin) within beta-cells of the pancreas. T2DM increases pathological angiogenesis and immature vascularisation. This also leads to chronic cerebral hypoperfusion, which results in dysfunction and degeneration of neuroglial cells. With an abundance of common mechanisms underpinning both disorders, a significant question that can be posed is whether T2DM leads to AD in aged individuals and the associations between other protein misfolding diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“7 million by 2030, unless countermeasures can be found and successfully applied [39].”
BackgroundSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 5×
“Thereafter, a γsecretase complex, which comprises PS1 or PS2, nicastrin, anterior pharynx-defective-1 (APH-1), and presenilin enhancer-2 (PEN-2), cleaves the remaining fragment of membrane bound APP at the C-terminus resulting in the generation of monomeric Aβ peptides of varying lengths [25, 51, 56].”
BackgroundInfluentialCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“The aggregates, known as neuritic plaques, chiefly comprise of amyloid-β peptide (Aβ), which is formed by the proteolytic cleavage of amyloid precursor protein (APP) [10], a large type I integral membrane protein of 695–770 aa that is expressed in many tissues but particularly concentrated within the synapse of neuron…”
BackgroundNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“Extracellular accumulation of Aβ, as discussed, appears to represent the first lesion (with declines in CSF levels of Aβ) that forms years before clinical signs; while the induction of NFTs, CAA, neuroinflammation and synaptic loss initiates self-sustaining cycles that drives disease progression towards development of…”
Background
Research works printed but not linked: 4
- [3]Bai Y Nussinov R Protein Folding Protocols Springer 2007
- [8]Pietzsch J Protein Folding diseases http://www.nature.com/horizon/proteinfolding/background/disease.html
- [22]Cooper GM Protein Folding and Processing http://www.ncbi.nlm.nih.gov/books/NBK9843/
- [91]Tycko R Proteopathic Seeds and Neurodegenerative Diseases Jucker M Christen Y Springer Berlin Heidelberg 2013 19 31
Cited by
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data
Sun, D., Guan, X., Moran, A. E., Wu, L.-Y., Qian, D. Z., Schedin, P., Dai, M.-S., Danilov, A. V., Alumkal, J. J., Adey, A. C., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01091-3 · Cited by 503
“In oligodendrocytes and OPCs, multiple heat shock and chaperone genes involving proper protein folding (e.g., HSPA1A, HSPB1, DNAJB1) were up-regulated in Scissor+ cells, consistent with the previous observation 38 .”
Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases
Ghemrawi, R., & Khair, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176127 · Cited by 398
“Neuronal cells are particularly sensitive to protein misfolding, thus, excessive misfolding and aggregation lead to disrupted function of synapses, apoptosis and selective neuronal death [20] (Figure 2).”
BackgroundGadhave, D. G., Sugandhi, V. V., Jha, S. K., Nangare, S. N., Gupta, G., Singh, S. K., Dua, K., Cho, H., Hansbro, P. M., & Paudel, K. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102357 · Cited by 358
“They are thought to be the primary reason for these disorders (Ashraf et al., 2014; Khanam et al., 2016).”
BackgroundLeszek, J., E. Barreto, G., G|siorowski, K., Koutsouraki, E., Ávila-Rodrigues, M., & Aliev, G. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160202125914 · Cited by 206
The Possibility of an Infectious Etiology of Alzheimer Disease
Ashraf, G. M., Tarasov, V. V., Makhmutovа, A., Chubarev, V. N., Avila-Rodriguez, M., Bachurin, S. O., & Aliev, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1388-y · Cited by 175
Self-citation
Metadata
- Authors
- Ashraf, G., Greig, N., Khan, T., Hassan, I., Tabrez, S., Shakil, S., Sheikh, I., Zaidi, S., Akram, M., Jabir, N., Firoz, C., Naeem, A., Alhazza, I., Damanhouri, G., & Kamal, M.
- Affiliations
- King Abdulaziz University (SA)
- National Institutes of Health (US)
- Sur University College (OM)
- King Saud University (SA)
- Integral University (IN)
- Aligarh Muslim University (IN)
- Corresponding author
- Akram, Mohammad
- ORCID
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2014-10-15
- Volume
- 13
- Issue
- 7
- Pages
- 1280-1293
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- PMC
- PMC5193501
- OpenAlex
- W2134099103
- Cited by
- 236
- References
- 170
- Citations by year
- 2026: 11 · 2025: 34 · 2024: 35 · 2023: 36 · 2022: 18 · 2021: 24 · 2020: 23 · 2019: 15 · 2018: 13 · 2017: 12 · 2016: 8 · 2015: 6 · 2014: 1
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (ZIAAG000311)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, protein aggregation, Alzheimer's disease, type 2 diabetes, amyloid-beta, amylin, β-sheet conformation, amyloid fibrils, alpha-helix to beta-sheet transition, molecular chaperones, neurodegeneration, vascular dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Diabetes Mellitus, Type 2, Humans, Intermediate Filaments, Amyloid beta-Peptides, tau Proteins, Protein Folding, alpha-Synuclein, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.2174/1871527313666140917095514
- The paper
- Ashraf, G., Greig, N., Khan, T., Hassan, I., Tabrez, S., Shakil, S., Sheikh, I., Zaidi, S., Akram, M., Jabir, N., Firoz, C., Naeem, A., Alhazza, I., Damanhouri, G., & Kamal, M. (2014). Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527313666140917095514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.